Biodefense Protection Technologies Laboratory (BPT-L)
Biodefense Protection Technologies Laboratory (BPT-L)



Biodefense Protection Technologies Laboratory
Soldier protection is an Army warfighting function. Biodefense Protection Technologies Laboratory (BPT-L) investigates and develops novel biology and engineering technologies to improve soldier protection in the areas of force health and CBRN operations.
Current projects include:
- Investigation of bacteriophage-host Interactions using single molecule localization microscopy
- Autoimmunity in a 3D-printed implanted biosensor
- Establishing porcine reproductive and Respiratory Syndrome Virus (PRRSV) as a department model for RNA virus research
- Evolution of avoidance behaviors: Theory and tests in a model organism
Our research group is first and foremost a leader development organization. We are improving leaders (cadets, field-grade officers, and DA civilians) through the disciplines of research (collaborations/teamwork, critical thinking, planning, attention to detail, reading/writing, SOPs & optimization). Additionally, we are contributing intellectual capital and building partnerships with Army laboratories to answer basic science and applied research questions fundamental to future (>10 years) soldier protection.

Recent Publications
- Kick AR, Grete AF, Crisci E, Almond GW, Käser T. Testable Candidate Immune Correlates of Protection for Porcine Reproductive and Respiratory Syndrome Virus Vaccination. Vaccines. 2023; 11(3):594. https://doi.org/10.3390/vaccines11030594.
- Hummel S, Burpo FJ, Hershfield J, Kick A, O’Donovan KJ, Barnhill J. A New Age of Bioterror: Anticipating Exploitation of Tunable Viral Agents. CTC Sentinel. 2022;15(4):1-6. Accessed June 22, 2022.
- Kick A, Lagasse B, Hummel S, Gettings M, Bowers P, Burpo FJ. Army Officer Corps Science, Technology, Engineering and Mathematics (STEM) Foundation Gaps Place Countering Weapons of Mass Destruction (CWMD) Operations at Risk – Part 2. CWMD Journal. 2022;Spring / Summer 2022(24):33-41.

